Download full list or filter/search for your target below.
| Common Name | Gene | Full Gene Name | Protein Name | Category/Type | Uniprot ID |
|---|---|---|---|---|---|
| ab38 | Abeta38 | Amyloid Beta Precursor Protein | Amyloid-beta precursor protein | Amyloid and Tau Pathologies | P05067 |
| ab40 | Abeta40 | Amyloid Beta Precursor Protein | Amyloid-beta precursor protein | Amyloid and Tau Pathologies | P05067 |
| ab42 | Abeta42 | Amyloid Beta Precursor Protein | Amyloid-beta precursor protein | Amyloid and Tau Pathologies | P05067 |
| ACHE | ACHE | Acetylocholinesterase (Cartwright Blood Group) | Acetylcholinesterase | Amyloid and Tau Pathologies | P22303 |
| AGRN | AGRN | Agrin | Agrin | Synuclein and Synaptic Discorders | O00468 |
| ANXA5 | ANXA5 | Annexin A5 | Annexin A5 | Neurodegeneration | P08758 |
| APOE | APOE | Apolipoprotein E | Apolipoprotein E | Amyloid and Tau Pathologies | P02649 |
| APOE4 | APOE | Apolipoprotein E isoform 4 | Apolipoprotein E isoform 4 | Amyloid and Tau Pathologies | P02649 |
| ARSA | ARSA | Arylsulfatase A | Arylsulfatase A | Synuclein and Synaptic Discorders | P15289 |
| BACE1 | BACE1 | Beta-Secretase 1 | Beta-secretase 1 | Amyloid and Tau Pathologies | P56817 |
| BASP1 | BASP1 | Brain Abundant Membrane Attached Signal Protein 1 | Brain acid soluble protein 1 | Amyloid and Tau Pathologies | P80723 |
| BDNF | BDNF | Brain Derived Neurotrophic Factor | Brain-derived neurotrophic factor | Synuclein and Synaptic Discorders | P23560 |
| CALB2 | CALB2 | Calbindin 2 | Calretinin | Neurodegeneration | P22676 |
| CD40L/TNFSF5 | CD40LG | CD40 Ligand | CD40 ligand | Inflammation | P29965 |
| CD63 | CD63 | CD63 Molecule | CD63 antigen | Amyloid and Tau Pathologies | P08962 |
| CHIT1 | CHIT1 | Chitinase 1 | Chitotriosidase-1 | Inflammation | Q13231 |
| CNTN2 | CNTN2 | Contactin 2 | Contactin-2 | Neurodegeneration | Q02246 |
| CRH | CRH | Corticotropin Releasing Hormone | Corticoliberin | Inflammation | P06850 |
| CRP | CRP | C-Reactive Protein | C-reactive protein | Inflammation | P02741 |
| CST3 | CST3 | Cystatin 3 | Cystatin-C | Amyloid and Tau Pathologies | P01034 |
| CX3CL1/Fractalkine | CX3CL1 | C-X3-C Motif Chemokine Ligand 1 | Fractalkine | Inflammation | P78423 |
| CXCL1/GROa | CXCL1 | C-X-C Motif Chemokine Ligand 1 | Growth-regulated alpha protein | Inflammation | P09341 |
| DDC | DDC | Aromatic-L-Amino-Acid Decarboxylase | Aromatic-L-Amino-Acid Decarboxylase | Synuclein and Synaptic Discorders | P20711 |
| ENO2 | ENO2 | Enolase 2 | Gamma-enolase | Neurodegeneration | P09104 |
| Eotaxin | CCL11 | C-C Motif Chemokine Ligand 11 | Eotaxin | Inflammation | P51671 |
| Eotaxin-3 | CCL26 | C-C Motif Chemokine Ligand 26 | C-C motif chemokine 26 | Inflammation | Q9Y258 |
| FABP3 | FABP3 | Fatty Acid Binding Protein 3 | Fatty acid-binding protein, heart | Synuclein and Synaptic Discorders | P05413 |
| FCN2 | FCN2 | Ficolin 2 | Ficolin-2 | Inflammation | Q15485 |
| FGF basic | FGF2 | Fibroblast Growth Factor 2 | Fibroblast growth factor 2 | Neurodegeneration | P09038 |
| FOLR1 | FOLR1 | Folate Receptor Alpha | Folate receptor alpha | Synuclein and Synaptic Discorders | P15328 |
| GDF15 | GDF15 | Growth Differentiation Factor 15 | Growth/differentiation factor 15 | Inflammation | Q99988 |
| GDI1 | GDI1 | Rab GDP Dissociation Inhibitor Alpha | Rab GDP dissociation inhibitor alpha | Neurodegeneration | P31150 |
| GDNF | GDNF | Glial Cell Derived Neurotrophic Factor | Glial cell line-derived neurotrophic factor | Neurodegeneration | P39905 |
| GFAP | GFAP | Glial Fibrillary Acidic Protein | Glial fibrillary acidic protein | Inflammation | P14136 |
| GM-CSF | CSF2 | Colony Stimulating Factor 2 | Granulocyte-macrophage colony-stimulating factor | Inflammation | P04141 |
| GOT1 | GOT1 | Glutamic-Oxaloacetic Transaminase 1 | Aspartate aminotransferase, cytoplasmic | Neurodegeneration | P17174 |
| HBα1; HBα2 | HBA1; HBA2 | Hemoglobin Subunit Alpha 1 | Hemoglobin subunit alpha 1 |Hemoglobin subunit alpha 2 | Vascular | P69905 |
| HTT | HTT | Huntingtin | Huntingtin | Synuclein and Synaptic Discorders | P42858 |
| ICAM1 | ICAM1 | Intercellular Adhesion Molecule 1 | Intercellular adhesion molecule 1 | Inflammation | P05362 |
| IFN-gamma | IFNG | Interferon Gamma | Interferon gamma | Inflammation | P01579 |
| IGF1R | IGF1R | Insulin Like Growth Factor 1 Receptor | Insulin-like growth factor 1 Receptor | Inflammation | P08069 |
| IGFBP7 | IGFBP7 | Insulin Like Growth Factor Binding Protein 7 | Insulin-like growth factor-binding protein 7 | Amyloid and Tau Pathologies | Q16270 |
| IL-1 beta | IL1B | Interleukin 1 Beta | Interleukin-1 beta | Inflammation | P01584 |
| IL-2 | IL2 | Interleukin 2 | Interleukin-2 | Inflammation | P60568 |
| IL-4 | IL4 | Interleukin 4 | Interleukin-4 | Inflammation | P05112 |
| IL-5 | IL5 | Interleukin 5 | Interleukin-5 | Inflammation | P05113 |
| IL-6 | IL6 | Interleukin 6 | Interleukin-6 | Inflammation | P05231 |
| IL-6R a | IL6R | Interleukin 6 Receptor | Interleukin-6 receptor subunit alpha | Synuclein and Synaptic Discorders | P08887 |
| IL-7 | IL7 | Interleukin 7 | Interleukin-7 | Inflammation | P13232 |
| IL-9 | IL9 | Interleukin 9 | Interleukin-9 | Inflammation | P15248 |
| IL-10 | IL10 | Interleukin 10 | Interleukin-10 | Inflammation | P22301 |
| IL-12p70 | IL12A|IL12B | Interleukin 12A | Interleukin 12B | Interleukin 12A | Interleukin 12B | Inflammation | P29459|P29460 |
| IL-13 | IL13 | Interleukin 13 | Interleukin-13 | Inflammation | P35225 |
| IL-15 | IL15 | Interleukin 15 | Interleukin-15 | Inflammation | P40933 |
| IL-16 | IL16 | Interleukin 16 | Pro-interleukin-16 | Inflammation | Q14005 |
| IL-17A | IL17A | Interleukin 17A | Interleukin-17A | Inflammation | Q16552 |
| IL-18 | IL18 | Interleukin 18 | Interleukin-18 | Inflammation | Q14116 |
| IL-33 | IL33 | Interleukin 33 | Interleukin-33 | Inflammation | O95760 |
| IL8 | CXCL8 | C-X-C Motif Chemokine Ligand 8 | Interleukin-8 | Inflammation | P10145 |
| IP-10 | CXCL10 | C-X-C Motif Chemokine Ligand 10 | C-X-C motif chemokine 10 | Inflammation | P02778 |
| KLK6 | KLK6 | Kallikrein Related Peptidase 6 | Kallikrein-6 | Amyloid and Tau Pathologies | Q92876 |
| MCP1 | CCL2 | C-C Motif Chemokine Ligand 2 | C-C motif chemokine 2 | Inflammation | P13500 |
| MCP4 | CCL13 | C-C Motif Chemokine Ligand 13 | C-C motif chemokine 13 | Inflammation | Q99616 |
| MDC | CCL22 | C-C Motif Chemokine Ligand 22 | C-C motif chemokine 22 | Inflammation | O00626 |
| MDH1 | MDH1 | Malate Dehydrogenase 1 | Malate dehydrogenase, cytoplasmic | Synuclein and Synaptic Discorders | P40925 |
| MIP1a/CCL3 | CCL3 | C-C Motif Chemokine Ligand 3 | C-C motif chemokine 3 | Inflammation | P10147 |
| Mip1b/CCL4 | CCL4 | C-C Motif Chemokine Ligand 4 | C-C motif chemokine 4 | Inflammation | P13236 |
| MME | MME | Membrane Metalloendopeptidase | Neprilysin | Vascular and Metabolism | P08473 |
| MSLN | MSLN | Mesothelin | Mesothelin | Neurodegeneration | Q13421 |
| NEFH | NEFH | Neurofilament Heavy Chain | Neurofilament heavy polypeptide | Neurodegeneration | P12036 |
| NfL | NEFL | Neurofilament Light Chain | Neurofilament light polypeptide | Neurodegeneration | P07196 |
| NGF | NGF | Nerve Growth Factor | Beta-nerve growth factor | Synuclein and Synaptic Discorders | P01138 |
| NPTX1 | NPTX1 | Neuronal Pentraxin 1 | Neuronal pentraxin-1 | Neurodegeneration | Q15818 |
| NPTX2 | NPTX2 | Neuronal Pentraxin 2 | Neuronal pentraxin-2 | Neurodegeneration | P47972 |
| NPTXR | NPTXR | Neuronal Pentraxin Receptor | Neuronal pentraxin receptor | Neurodegeneration | O95502 |
| NPY | NPY | Neuropeptide Y | Pro-neuropeptide Y | Neurodegeneration | P01303 |
| NRGN | NRGN | Neurogranin | Neurogranin | Neurodegeneration | Q92686 |
| PARK7 | PARK7 | Parkinsonism Associated Deglycase | Parkinson disease protein 7 | Synuclein and Synaptic Discorders | Q99497 |
| PDGFRB | PDGFRB | Platelet Derived Growth Factor Receptor Beta | Platelet-derived growth factor receptor beta | Vascular and Metabolism | P09619 |
| PDLIM5 | PDLIM5 | PDZ And LIM Domain 5 | PDZ and LIM domain protein 5 | Neurodegeneration | Q96HC4 |
| PGK1 | PGK1 | Phosphoglycerate Kinase 1 | Phosphoglycerate kinase 1 | Vascular and Metabolism | P00558 |
| PLGF | PGF | Placental Growth Factor | Placenta growth factor | Vascular | P49763 |
| POSTN | POSTN | Periostin | Periostin | Vascular and Metabolism | Q15063 |
| PRDX6 | PRDX6 | Peroxiredoxin 6 | Peroxiredoxin-6 | Inflammation | P30041 |
| PSEN1 | PSEN1 | Presenilin 1 | Presenilin-1 | Amyloid and Tau Pathologies | P49768 |
| pSNCA-129 | SNCA | Phosphorylated alpha-synuclein | Phosphorylated alpha-synuclein at serine 129 | Synuclein and Synaptic Discorders | P37840 |
| pTau-181 (Brain-derived) | MAPT | Microtuble Associated Protein Tau | Brain-derived Tau, phosphorylated at T181 | Amyloid and Tau Pathologies | P10637 |
| pTau-217 (Brain-derived) | MAPT | Microtuble Associated Protein Tau | Brain-derived Tau, phsophorylated at T217 | Amyloid and Tau Pathologies | P10637 |
| pTau-231 (Brain-derived) | MAPT | Microtuble Associated Protein Tau | Brain-derived Tau, phsophorylated at T231 | Amyloid and Tau Pathologies | P10637 |
| pTau181 | pTau181 | Microtubule Associated Protein Tau | Microtubule-associated protein tau | Amyloid and Tau Pathologies | P10636 |
| pTau217 | pTau217 | Microtubule Associated Protein Tau | Microtubule-associated protein tau | Amyloid and Tau Pathologies | P10636 |
| pTau231 | pTau231 | Microtubule Associated Protein Tau | Microtubule-associated protein tau | Amyloid and Tau Pathologies | P10636 |
| PTN | PTN | Pleiotrophin | Pleiotrophin | Vascular and Metabolism | P21246 |
| REST | REST | RE1 Silencing Transcription Factor | RE1-silencing transcription factor | Neurodegeneration | Q13127 |
| RUVBL2 | RUVBL2 | RuvB Like AAA ATPase 2 | RuvB-like 2 | Inflammation | Q9Y230 |
| S100A12 | S100A12 | S100 Calcium Binding Protein A12 | Protein S100-A12 | Inflammation | P80511 |
| S100B | S100B | S100 Calcium Binding Protein B | Protein S100-B | Inflammation | P04271 |
| SAA1 | SAA1 | Serum Amyloid A1 | Serum amyloid A-1 protein | Vascular | P0DJI8 |
| SFRP1 | SFRP1 | Secreted Frizzled Related Protein 1 | Secreted frizzled-related protein 1 | Amyloid and Tau Pathologies | Q8N474 |
| SFTPD | SFTPD | Pulmonary Surfactant-Associated Protein | Pulmonary surfactant-associated protein D | Inflammation | P35247 |
| SLIT2 | SLIT2 | Slit Guidance Ligand 2 | Slit homolog 2 protein | Inflammation | O94813 |
| SMOC1 | SMOC1 | SPARC-related modular calcium-binding protein 1 | SPARC-related modular calcium-binding protein 1 | Neurodegeneration | Q9H4F8 |
| SNAP25 | SNAP25 | Synaptosome Associated Protein 25 | Synaptosomal-associated protein 25 | Neurodegeneration | P60880 |
| SNCAagg | Oligo-SNCA | Synuclein Alpha | Alpha-synuclein | Synuclein and Synaptic Discorders | P37840 |
| SOD1 | SOD1 | Superoxide Dismutase 1 | Superoxide dismutase [Cu-Zn] | Synuclein and Synaptic Discorders | P00441 |
| SQSTM1 | SQSTM1 | Sequestosome 1 | Sequestosome-1 | Neurodegeneration | Q13501 |
| sTREM1 | TREM1 | Triggering Receptor Expressed On Myeloid Cells 1 | Triggering Receptor Expressed On Myeloid Cells 2 | Inflammation | Q9NP99 |
| TAFA5 | TAFA5 | TAFA Chemokine Family Member 5 | Chemokine-like protein TAFA-5 | Inflammation | Q7Z5A7 |
| TARC/CCL17 | CCL17 | C-C Motif Chemokine Ligand 17 | C-C motif chemokine 17 | Inflammation | Q92583 |
| TARDBP | TARDBP | TAR DNA Binding Protein | TDP-43 with phosphorylation on serine 409 | Synuclein and Synaptic Discorders | Q13148 |
| TDP43 | TARDBP | TAR DNA Binding Protein | TAR DNA-binding protein 43 | Synuclein and Synaptic Discorders | Q13148 |
| Tie-2/TEK | TEK | TEK Receptor Tyrosine Kinase | Angiopoietin-1 receptor | Inflammation | Q02763 |
| TIMP3 | TIMP3 | TIMP Metallopeptidase Inhibitor 3 | Metalloproteinase inhibitor 3 | Inflammation | P35625 |
| TNF-a | TNF | Tumor Necrosis Factor | Tumor necrosis factor | Inflammation | P01375 |
| totalTau | tTau | Microtubule Associated Protein Tau | Microtubule-associated protein tau | Amyloid and Tau Pathologies | P10636 |
| totalTau (Brain-derived) | MAPT | Microtuble Associated Protein Tau | Brain-derived Tau | Amyloid and Tau Pathologies | P10637 |
| TREM2 | TREM2 | Triggering Receptor Expressed on Myeloid Cells 2 | Triggering receptor expressed on myeloid cells 2 | Inflammation | Q9NZC2 |
| UBB | UBB | Polyubiquitin-B | Polyubiquitin-B | Neurodegeneration | P0CG47 |
| UCHL1 | UCHL1 | Ubiquitin C-Terminal Hydrolase L1 | Ubiquitin C-terminal hydrolase L1 | Synuclein and Synaptic Discorders | P09936 |
| VCAM1/CD106 | VCAM1 | Vascular Cell Adhesion Molecule 1 | Vascular cell adhesion protein 1 | Inflammation | P19320 |
| VEGF R1 | FLT1 | Fms Related Receptor Tyrosine Kinase 1 | Vascular endothelial growth factor receptor 1 | Vascular and Metabolism | P17948 |
| VEGF R2 | KDR | Kinase Insert Domain Receptor | Vascular endothelial growth factor receptor 2 | Vascular and Metabolism | P35968 |
| VEGF-A | VEGFA | Vascular Endothelial Growth Factor A | Vascular endothelial growth factor A | Vascular | P15692 |
| VEGF-D | VEGFD | Vascular Endothelial Growth Factor D | Vascular endothelial growth factor D | Vascular | O43915 |
| VGF | VGF | Neurosecretory protein VGF | Neurosecretory protein VGF | Synuclein and Synaptic Discorders | O15240 |
| VILIP-1 | VSNL1 | Visinin Like 1 | Visinin-like protein 1 | Neurodegeneration | P62760 |
| YKL40 | CHI3L1 | Chitinase 3 Like 1 | Chitinase-3-like protein 1 | Inflammation | P36222 |
| YWHAG | YWHAG | Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Gamma | 14-3-3 protein gamma-B | Neurodegeneration | P61981 |
| YWHAZ | YWHAZ | Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Zeta | 14-3-3 protein zeta/delta | Neurodegeneration | P63104 |
| α-Syn | SNCA | Synuclein Alpha | Alpha-synuclein | Synuclein and Synaptic Discorders | P37840 |
| β-syn | SNCB | Beta-synuclein | Beta-synuclein | Synuclein and Synaptic Discorders | Q16143 |
FOR RESEARCH USE ONLY. Not for use in diagnostic procedures.
CSO
Dr. Willams serves as the company’s Chief Scientific Officer. He was previously Chief Medical Officer at Standard Biotools and at SomaLogic where he pioneered the discipline for discovery and validation of predictive, diagnostic and prognostic models using machine-learning applied to large-plex proteomics. 20 such tests were used for drug characterization, safety and efficacy when incorporated in clinical drug trials at Pharma/Biotech and 17 different multivariate tests were validated and translated into regulated healthcare uses. Prior to SomaLogic, Dr. Williams was at Pfizer in the UK and the USA as a clinical triallist in Translational Medicine, and subsequently as VP, Global Clinical Technology. He sat on the National Advisory Council for the National Institute of Biomedical Imaging and Bioengineering, the Executive Committee for the FNIH Biomarkers Consortium, and worked with FDA and PhRMA on developing evidentiary standards for biomarker qualification. Dr. William’s medical training was in London, at Charing Cross and Westminster Medical School, followed by a PhD in medicine/physiology at the same institution and training in Radiology at the University of Newcastle Upon Tyne. Steve is co-inventor on 26 proteomics patents and author/coauthor on multiple foundational proteomics manuscripts.
CFO
Mr. McAnear serves as the company’s Chief Financial Officer. He brings over 25 years of operational and financial leadership experience across various sectors and was instrumental in taking 10x Genomics public in 2019, serving as its CFO for over five years. Mr. McAnear served for over 3 years as Tesla’s VP of Worldwide Finance and Operations, supporting landmark initiatives such as the Model X and Model 3 launches and Solar City acquisition. He also held various roles at Apple and J&J earlier in his career and served as a naval officer and aviator for over 9 years.